DH
Therapeutic Areas
Nuvation Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FDA-Approved Treatment (unspecified) | Oncology | Approved |
Leadership Team at Nuvation Bio
DH
David Hung, M.D.
Founder, President and Chief Executive Officer, Chairman of the Board of Directors
RB
Robert Bazemore
Lead Independent Director, Board of Directors
WA
Wassim Abida, M.D., Ph.D.
Scientific Advisory Board Member
JD
Johann de Bono, M.D., MSc, Ph.D.
Scientific Advisory Board Member